SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SABRATEK CORP (SBTK)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RockyBalboa who wrote (454)8/24/1999 8:08:00 PM
From: celeryroot.com   of 487
 
sorry if this posted before

NEW YORK, Aug. 24 /PRNewswire/ -- Sabratek Corp. (Nasdaq: SBTK) and one of
its senior officers have been named in a securities lawsuit filed on
August 24, 1999 in the U.S. District Court for the Northern District of
Illinois. The lawsuit was filed on behalf of all persons who purchased
Sabratek common stock during the period May 11, 1999 through August 13, 1999.
The Complaint alleges that the repeated misleading positive announcements
made by Sabratek during the class period left the unmistakable impression that
the company was in the midst of numerous positive acquisitions that would be
extremely beneficial to its shareholders. The defendants failed to disclose
that at the very same time they were making these positive announcements, the
company's business was in disarray and its earnings for the upcoming quarter
would be nowhere near what the marketplace had been led to believe.
Investors who purchased Sabratek common stock during the class period have
until October 23, 1999 to seek to be a lead plaintiff in the class action,
commenced by the law firm of Wolf Popper LLP.
Wolf Popper LLP has successfully recovered billions of dollars for
defrauded investors and shareholders. The reputation and expertise of the
firm in shareholder and other class action litigation have been repeatedly
recognized by the courts, which have appointed the firm lead counsel in
complex multi-district and consolidated litigations.
Persons with information or questions concerning the class action should
contact Wolf Popper LLP through its toll-fee number (877-370-7703), or at
canderson@wolfpopper.com.

CONTACT: Catherine E. Anderson, Esq.
Wolf Popper LLP
845 Third Avenue
New York, NY 10022-6689
Telephone: 212-451-9623
Toll Free: 877-370-7703
Facsimile: 212-486-2093
E-Mail: canderson@wolfpopper.com or wolfpopper@aol.com
Website: wolfpopper.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext